Targeting vascular endothelial growth factor using retinal gene therapy

Pharmacotherapies targeting vascular endothelial growth factor (VEGF) have revolutionized the management for neovascular retinal disorders including diabetic retinopathy and neovascular age-related macular degeneration. However, the burden of frequent injections, high cost, and treatment resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Sook H., Frick, Sonia L., Yiu, Glenn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article on Novel Tools and Therapies for Ocular Regeneration
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421957/
https://www.ncbi.nlm.nih.gov/pubmed/34532414
http://dx.doi.org/10.21037/atm-20-4417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421957/
https://www.ncbi.nlm.nih.gov/pubmed/34532414
http://dx.doi.org/10.21037/atm-20-4417

Ejemplares similares